EMETANT-IV

Emetant 150mg Injection is utilized for the management of nausea and vomiting. It is frequently employed to address both acute and delayed nausea and vomiting that occur as a result of cancer treatments, such as high-dose cisplatin (which is highly emetogenic) and moderately emetogenic chemotherapy. It is important to note that contraceptives may not function effectively during the administration of Emetant 150mg Injection.

The concurrent use of warfarin can significantly impact blood clotting times, making it essential to monitor patients who are on long-term warfarin therapy prior to starting Emetant 150mg Injection. This medication is contraindicated for individuals with hypersensitivity. The prescribed dosage regimen may include oral dexamethasone as part of the treatment plan. It is crucial to inform your physician of any existing medical conditions. Additionally, notify your doctor if you are undergoing warfarin therapy or using contraceptive medications.